Condensed Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 2,628,286	$ 3,892,919
Accounts receivable	91	56
Inventory, net	141,831	143,756
Other current assets	280,784	301,077
Total current assets	3,050,992	4,337,808
Intangible assets, net	22,633,161	23,748,328
Property and equipment, net	494,387	559,645
Other assets	174,536	174,418
Total assets	26,353,076	28,820,199
Current liabilities:
Contract liabilities		106,329
Convertible notes payable (including amounts of related party of nil and $2,000,000 as of March 31, 2025, and December 31, 2024, respectively)	1,000,000	3,000,000
Accrued expenses and others current liabilities	523,467	848,615
Total current liabilities	1,523,467	3,954,944
Convertible notes payable - noncurrent (including amounts of related party of $11,000,000 and $9,000,000 as of March 31,2025 and December 31, 2024, respectively)	11,000,000	9,000,000
Other long-term liabilities	707,957	348,945
Total liabilities	13,231,424	13,303,889
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding
Common stock, $0.01 par value; 300,000,000 shares authorized as of March 31, 2025, and December 31, 2024, 17,215,164 and 15,427,385 shares issued and outstanding as of March 31, 2025, and December 31, 2024, respectively	172,152	154,274
Additional paid-in capital	69,435,008	68,520,881
Accumulated deficit	(56,035,338)	(52,749,316)
Accumulated other comprehensive loss - translation adjustment	(450,170)	(409,529)
Total stockholders’ equity	13,121,652	15,516,310
Total liabilities and stockholders’ equity	$ 26,353,076	$ 28,820,199